189 related articles for article (PubMed ID: 9458894)
1. PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats.
McMahon LR; Wellman PJ
Am J Physiol; 1998 Jan; 274(1):R23-9. PubMed ID: 9458894
[TBL] [Abstract][Full Text] [Related]
2. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
[TBL] [Abstract][Full Text] [Related]
3. The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.
Seeley RJ; Blake K; Rushing PA; Benoit S; Eng J; Woods SC; D'Alessio D
J Neurosci; 2000 Feb; 20(4):1616-21. PubMed ID: 10662851
[TBL] [Abstract][Full Text] [Related]
4. Decreased intake of a liquid diet in nonfood-deprived rats following intra-PVN injections of GLP-1 (7-36) amide.
McMahon LR; Wellman PJ
Pharmacol Biochem Behav; 1997 Nov; 58(3):673-7. PubMed ID: 9329057
[TBL] [Abstract][Full Text] [Related]
5. Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons.
Katsurada K; Maejima Y; Nakata M; Kodaira M; Suyama S; Iwasaki Y; Kario K; Yada T
Biochem Biophys Res Commun; 2014 Aug; 451(2):276-81. PubMed ID: 25089000
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
Tang-Christensen M; Vrang N; Larsen PJ
Diabetes; 1998 Apr; 47(4):530-7. PubMed ID: 9568683
[TBL] [Abstract][Full Text] [Related]
7. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
8. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness.
Kinzig KP; D'Alessio DA; Seeley RJ
J Neurosci; 2002 Dec; 22(23):10470-6. PubMed ID: 12451146
[TBL] [Abstract][Full Text] [Related]
9. Anxiogenic-like action of centrally administered glucagon-like peptide-1 in a punished drinking test.
Möller C; Sommer W; Thorsell A; Rimondini R; Heilig M
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):119-22. PubMed ID: 11853101
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 (7-36) amide administered into the third cerebroventricle inhibits water intake in rats.
Wang T; Edwards GL; Baile CA
Proc Soc Exp Biol Med; 1998 Oct; 219(1):85-91. PubMed ID: 9751227
[TBL] [Abstract][Full Text] [Related]
11. Intracerebroventricular glucagon-like peptide-1 (7-36) amide inhibits sham feeding in rats without eliciting satiety.
Asarian L; Corp ES; Hrupka B; Geary N
Physiol Behav; 1998 Jun; 64(3):367-72. PubMed ID: 9748106
[TBL] [Abstract][Full Text] [Related]
12. Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats.
Schick RR; Zimmermann JP; vorm Walde T; Schusdziarra V
Am J Physiol Regul Integr Comp Physiol; 2003 Jun; 284(6):R1427-35. PubMed ID: 12776726
[TBL] [Abstract][Full Text] [Related]
13. A role for glucagon-like peptide-1 in the central regulation of feeding.
Turton MD; O'Shea D; Gunn I; Beak SA; Edwards CM; Meeran K; Choi SJ; Taylor GM; Heath MM; Lambert PD; Wilding JP; Smith DM; Ghatei MA; Herbert J; Bloom SR
Nature; 1996 Jan; 379(6560):69-72. PubMed ID: 8538742
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin: effects of hypothalamic and intravenous injections on eating and drinking in rats.
Stanley BG; Hoebel BG; Leibowitz SF
Peptides; 1983; 4(4):493-500. PubMed ID: 6685868
[TBL] [Abstract][Full Text] [Related]
15. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
Tang-Christensen M; Larsen PJ; Göke R; Fink-Jensen A; Jessop DS; Møller M; Sheikh SP
Am J Physiol; 1996 Oct; 271(4 Pt 2):R848-56. PubMed ID: 8897973
[TBL] [Abstract][Full Text] [Related]
16. Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion.
Thiele TE; van Dijk G; Yagaloff KA; Fisher SL; Schwartz M; Burn P; Seeley RJ
Am J Physiol; 1998 Jan; 274(1):R248-54. PubMed ID: 9458925
[TBL] [Abstract][Full Text] [Related]
17. Glucagon and the paraventricular hypothalamus: modulation of energy balance.
Atrens DM; Menéndez JA
Brain Res; 1993 Dec; 630(1-2):245-51. PubMed ID: 8118690
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide containing pathways in the regulation of feeding behaviour.
Tang-Christensen M; Vrang N; Larsen PJ
Int J Obes Relat Metab Disord; 2001 Dec; 25 Suppl 5():S42-7. PubMed ID: 11840214
[TBL] [Abstract][Full Text] [Related]
19. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
[TBL] [Abstract][Full Text] [Related]
20. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
